Publication:
Development of an inactivated 3Cpro-3ABC (mu3ABC) ELISA to differentiate cattle infected with foot and mouth disease virus from vaccinated cattle

dc.contributor.authorVasinee Srisombunditen_US
dc.contributor.authorNattarat Tungthumniyomen_US
dc.contributor.authorWilai Linchongsubongkochen_US
dc.contributor.authorChalermpol Lekcharoensuken_US
dc.contributor.authorLadawan Sariyaen_US
dc.contributor.authorPongrama Ramasootaen_US
dc.contributor.authorPorntippa Lekcharoensuken_US
dc.contributor.otherKasetsart Universityen_US
dc.contributor.otherRegional Reference Laboratory for Foot and Mouth Disease in Southeast Asiaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T05:05:09Z
dc.date.available2018-10-19T05:05:09Z
dc.date.issued2013-03-01en_US
dc.description.abstractFoot and mouth disease, a highly contagious disease of cloven-hoofed animals, is still endemic in Asia, Africa, and a few countries in South America. Subclinical and persistent infections usually occur in vaccinated cattle exposed to FMDV. Successful control and eradication measures need a diagnostic assay that can distinguish between immune responses to infection and vaccination. The non-structural 3ABC ELISA is the most reliable differential diagnostic assay. However, expression of the native 3ABC gene in insect cells yielded truncated versions of the proteins; thus, a monoclonal antibody to capture digested proteins is needed to develop the assay. The purpose of this study was to develop a simple indirect 3ABC ELISA using complete 3ABC protein. The full-length mutated 3ABC protein with inactive 3Cpro(mu3ABC) gene was constructed. The histidine-tagged mu3ABC protein was produced in insect cells for easy purification and measuring. This permits simple assay design and reproducible assay development. mu3ABC ELISA had diagnostic specificity and sensitivity of 96.6% and 84%, respectively, compared to Ceditest®FMDV-NS. Agreement of both assays was excellent with κ value of 0.823 (p<0.05). The mu3ABC ELISA could distinguish infected from vaccinated animals. These factors are necessary for the successful development of an in-house NSP-based ELISA. Availability of a reliable assay with acceptable costs would facilitate successful disease control and the establishment of disease-free zones. Expansion of such zones may ultimately decrease the risk of introducing FMDV into disease-free countries, thus accelerating global FMD control. © 2013 Elsevier B.V.en_US
dc.identifier.citationJournal of Virological Methods. Vol.188, No.1-2 (2013), 161-167en_US
dc.identifier.doi10.1016/j.jviromet.2012.12.016en_US
dc.identifier.issn18790984en_US
dc.identifier.issn01660934en_US
dc.identifier.other2-s2.0-84875270799en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/31954
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84875270799&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.titleDevelopment of an inactivated 3Cpro-3ABC (mu3ABC) ELISA to differentiate cattle infected with foot and mouth disease virus from vaccinated cattleen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84875270799&origin=inwarden_US

Files

Collections